TFP5, a peptide derived from p35, a Cdk5 neuronal activator, rescues cortical neurons from glucose toxicity. 2014

B K Binukumar, and Ya-Li Zheng, and Varsha Shukla, and Niranjana D Amin, and Philip Grant, and Harish C Pant
Laboratory of Neuronal Cytoskeletal protein Regulation Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.

Multiple lines of evidence link the incidence of diabetes to the development of Alzheimer's disease (AD). Patients with diabetes have a 50 to 75% increased risk of developing AD. Cyclin dependent kinase 5 (Cdk5) is a serine/threonine protein kinase, which forms active complexes with p35 or p39, found principally in neurons and in pancreatic β cells. Recent studies suggest that Cdk5 hyperactivity is a possible link between neuropathology seen in AD and diabetes. Previously, we identified P5, a truncated 24-aa peptide derived from the Cdk5 activator p35, later modified as TFP5, so as to penetrate the blood-brain barrier after intraperitoneal injections in AD model mice. This treatment inhibited abnormal Cdk5 hyperactivity and significantly rescued AD pathology in these mice. The present study explores the potential of TFP5 peptide to rescue high glucose (HG)-mediated toxicity in rat embryonic cortical neurons. HG exposure leads to Cdk5-p25 hyperactivity and oxidative stress marked by increased reactive oxygen species production, and decreased glutathione levels and superoxide dismutase activity. It also induces hyperphosphorylation of tau, neuroinflammation as evident from the increased expression of inflammatory cytokines like TNF-α, IL-1β, and IL-6, and apoptosis. Pretreatment of cortical neurons with TFP5 before HG exposure inhibited Cdk5-p25 hyperactivity and significantly attenuated oxidative stress by decreasing reactive oxygen species levels, while increasing superoxide dismutase activity and glutathione. Tau hyperphosphorylation, inflammation, and apoptosis induced by HG were also considerably reduced by pretreatment with TFP5. These results suggest that TFP5 peptide may be a novel candidate for type 2 diabetes therapy.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009474 Neurons The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM. Nerve Cells,Cell, Nerve,Cells, Nerve,Nerve Cell,Neuron
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D010770 Phosphotransferases A rather large group of enzymes comprising not only those transferring phosphate but also diphosphate, nucleotidyl residues, and others. These have also been subdivided according to the acceptor group. (From Enzyme Nomenclature, 1992) EC 2.7. Kinases,Phosphotransferase,Phosphotransferases, ATP,Transphosphorylase,Transphosphorylases,Kinase,ATP Phosphotransferases
D002540 Cerebral Cortex The thin layer of GRAY MATTER on the surface of the CEREBRAL HEMISPHERES that develops from the TELENCEPHALON and folds into gyri and sulci. It reaches its highest development in humans and is responsible for intellectual faculties and higher mental functions. Allocortex,Archipallium,Cortex Cerebri,Cortical Plate,Paleocortex,Periallocortex,Allocortices,Archipalliums,Cerebral Cortices,Cortex Cerebrus,Cortex, Cerebral,Cortical Plates,Paleocortices,Periallocortices,Plate, Cortical
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D051360 Cyclin-Dependent Kinase 5 A serine-threonine kinase that plays important roles in CELL DIFFERENTIATION; CELL MIGRATION; and CELL DEATH of NERVE CELLS. It is closely related to other CYCLIN-DEPENDENT KINASES but does not seem to participate in CELL CYCLE regulation. Cdk5 Protein Kinase,Cdc2-Related Kinase PSSALRE,Cdk5 Protein,Neuronal Cdc2-Like Protein Kinase,PSSALRE Protein,Cdc2 Related Kinase PSSALRE,Cyclin Dependent Kinase 5,Neuronal Cdc2 Like Protein Kinase,PSSALRE, Cdc2-Related Kinase,Protein Kinase, Cdk5

Related Publications

B K Binukumar, and Ya-Li Zheng, and Varsha Shukla, and Niranjana D Amin, and Philip Grant, and Harish C Pant
November 2023, Bulletin of experimental biology and medicine,
B K Binukumar, and Ya-Li Zheng, and Varsha Shukla, and Niranjana D Amin, and Philip Grant, and Harish C Pant
December 2015, Molecular biology of the cell,
B K Binukumar, and Ya-Li Zheng, and Varsha Shukla, and Niranjana D Amin, and Philip Grant, and Harish C Pant
October 2010, The Journal of biological chemistry,
B K Binukumar, and Ya-Li Zheng, and Varsha Shukla, and Niranjana D Amin, and Philip Grant, and Harish C Pant
January 2017, Scientific reports,
B K Binukumar, and Ya-Li Zheng, and Varsha Shukla, and Niranjana D Amin, and Philip Grant, and Harish C Pant
November 2016, Molecular biology of the cell,
B K Binukumar, and Ya-Li Zheng, and Varsha Shukla, and Niranjana D Amin, and Philip Grant, and Harish C Pant
August 2007, Biotechnology journal,
B K Binukumar, and Ya-Li Zheng, and Varsha Shukla, and Niranjana D Amin, and Philip Grant, and Harish C Pant
June 2007, The Journal of biological chemistry,
B K Binukumar, and Ya-Li Zheng, and Varsha Shukla, and Niranjana D Amin, and Philip Grant, and Harish C Pant
January 1997, Neuron,
B K Binukumar, and Ya-Li Zheng, and Varsha Shukla, and Niranjana D Amin, and Philip Grant, and Harish C Pant
October 2016, Neuroscience letters,
B K Binukumar, and Ya-Li Zheng, and Varsha Shukla, and Niranjana D Amin, and Philip Grant, and Harish C Pant
December 2009, Proceedings of the National Academy of Sciences of the United States of America,
Copied contents to your clipboard!